Common cholesterol drug could help prevent 'chemo brain' in cancer patients
More than 75 per cent of patients experience cognitive changes - known as 'chemo brain' - during treatment, with around 35 per cent reporting lingering symptoms years later.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.